Medeon Day was held this year in conjunction with AIM day Diabetes, Monday 26 September at the CRC in the Auditorium, SUS in Malmö. The theme was “Utilization and commercialization of research.”
Medeon in collaboration with LUDC, Lund University diabetes centre, have been running this programme for a number of years. It was an afternoon filled with interesting lectures by leading-edge researchers from LUDC and primary care. Current issues around Diabetes were also discussed.
CEO, Thomas Bäckström presented a short version of BTB Pharma’s vision and plan, how to commercialize its research in a near future.
Medeon, in cooperation with SEB, announced the winner of Medeonstipendiet, SEK 50 000, which this year was given to Associate Professor Ola Hansson from LUDC .